LeBoff M S, Shoback D, Brown E M, Thatcher J, Leombruno R, Beaudoin D, Henry M, Wilson R, Pallotta J, Marynick S
J Clin Invest. 1985 Jan;75(1):49-57. doi: 10.1172/JCI111696.
Alterations in parathyroid glandular sensitivity to calcium may contribute to the hypersecretion of PTH in hyperparathyroidism. Since the cytosolic calcium concentration may mediate the effects of extracellular calcium on PTH release, we have employed the calcium-sensitive intracellular dye QUIN-2 to examine the relationship between extracellular calcium, cytosolic calcium, and PTH secretion in adult, neonatal, and cultured bovine as well as pathological human parathyroid cells. PTH release was measured using C- and N-terminal radioimmunoassays. Neonatal bovine parathyroid cells showed a greater set-point for secretion (the Ca++ concentration causing half of the maximal inhibition of PTH release) than adult cells (1.27 +/- 0.11 vs. 1.06 +/- 0.11 mM extracellular calcium, P less than 0.01), and a slightly higher extracellular calcium was necessary to raise the cytosolic calcium concentration to a given level in neonatal than in adult bovine parathyroid cells. In individual neonatal and adult cell preparations, there was a close correlation between the set-point for secretion and the "set-point" for cytosolic calcium (r = 0.832, P less than 0.001). In cells from five human parathyroid adenomas, which had an increase in set-point for secretion, the extracellular calcium concentration necessary to raise the cytosolic calcium concentration to a given level was slightly greater than in the neonatal cells. In four preparations of human parathyroid cells there was a significant correlation between the set-points for secretion and cytosolic calcium (r = 0.856, P less than 0.01). Because neonatal bovine and pathological human parathyroid glands show cellular hyperplasia, we studied the temporal relationship between cellular proliferation and the regulation of PTH release and cytosolic calcium concentration in cultured bovine parathyroid cells. Cellular proliferation, estimated by 3H-thymidine incorporation, increased significantly in culture from 104 +/- 10.1 counts/well on day 1 (first 24 h in culture) to 588 +/- 188 and 6,156 +/- 649 counts/well on days 2 and 4, respectively. In cultured cells on day 1, highly Ca++ (2-3 mM) inhibited maximal PTH release by 58.8 +/- 3.2%, which decreased significantly (P less than 0.001) to 38.2 +/- 1.9 and 17.1 +/- 3.7% on days 2 and 4, respectively. The cytosolic calcium observed at 3 mM calcium on day 1 was 701 +/- 43 nM, which declined to 466 +/- 60 and 314 +/- 14 nM on days 2 and 4 (P less than 0.05). There was a close correlation between this progressive decrease in maximal inhibition of PTH release and the cytosolic calcium at high extracellular calcium in cultured cells (r = 0.99, P < 0.001). Thus, during active proliferation of cultured cells, there is an alteration in the regulation of cytosolic calcium at a given extracellular calcium concentration, and changes in the regulation of PTH release and cytosolic calcium by extracellular calcium may be related to enhanced cellular proliferation.
甲状旁腺对钙的敏感性改变可能导致甲状旁腺功能亢进时甲状旁腺激素(PTH)分泌过多。由于胞质钙浓度可能介导细胞外钙对PTH释放的影响,我们使用钙敏感的细胞内染料喹啉-2来研究成年、新生和培养的牛以及病理性人甲状旁腺细胞中细胞外钙、胞质钙与PTH分泌之间的关系。使用C端和N端放射免疫测定法测量PTH释放。新生牛甲状旁腺细胞的分泌设定点(导致PTH释放最大抑制一半的Ca++浓度)高于成年细胞(细胞外钙浓度分别为1.27±0.11和1.06±0.11 mM,P<0.01),并且将新生牛甲状旁腺细胞的胞质钙浓度提高到给定水平所需的细胞外钙略高于成年牛甲状旁腺细胞。在个体新生和成年细胞制剂中,分泌设定点与胞质钙“设定点”之间存在密切相关性(r = 0.832,P<0.001)。在来自五个甲状旁腺腺瘤的细胞中,其分泌设定点增加,将胞质钙浓度提高到给定水平所需的细胞外钙浓度略高于新生细胞。在四个人甲状旁腺细胞制剂中,分泌设定点与胞质钙之间存在显著相关性(r = 0.856,P<0.01)。由于新生牛和病理性人甲状旁腺显示细胞增生,我们研究了培养的牛甲状旁腺细胞中细胞增殖与PTH释放调节和胞质钙浓度之间的时间关系。通过3H-胸腺嘧啶掺入估计的细胞增殖在培养中从第1天(培养的前24小时)的104±10.1计数/孔显著增加到第2天和第4天的588±188和6156±649计数/孔。在第1天的培养细胞中,高Ca++(2-3 mM)抑制最大PTH释放58.8±3.2%,在第2天和第4天分别显著降低(P<0.001)至38.2±1.9%和17.1±3.7%。第1天在3 mM钙时观察到的胞质钙为701±43 nM,在第2天和第4天分别降至466±60和314±14 nM(P<0.05)。培养细胞中PTH释放最大抑制的这种逐渐降低与高细胞外钙时的胞质钙之间存在密切相关性(r = 0.99,P<0.001)。因此,在培养细胞的活跃增殖过程中,在给定的细胞外钙浓度下胞质钙调节发生改变,细胞外钙对PTH释放和胞质钙的调节变化可能与细胞增殖增强有关。